T

Terray Therapeutics, Inc.

Generative AI-powered small-molecule drug discovery platform

Scientist – Medicinal Chemistry

Translational Research & Bench BiologyPosted on Nov 18
Full-timeMonrovia, CA, USAIn-person

About the Job

Requirements

  • A Master of Science or Ph.D. in Organic Chemistry or a closely related chemical discipline.
  • One to two years of relevant industry experience or postdoctoral experience as an organic or medicinal chemist, with a strong track record of hands-on synthetic chemistry at the bench.
  • Experience collaborating with external synthesis resources, such as external contract research organization full-time equivalents.

Responsibilities

  • Drive progress across multiple pipeline programs during hit exploration, hit-to-lead, and lead optimization phases by efficiently synthesizing key analogs.
  • Design and execute robust synthetic routes for hit-to-lead analogs, critical intermediates, core scaffolds, and building blocks to support hit-to-lead and lead optimization initiatives.
  • Partner with Molecular Design, Medicinal Chemistry, and Machine Learning teams to evaluate computational tools and designs and strategically prioritize compounds for synthesis.
  • Collaborate with program leads to triage synthesis workflows and identify compounds best suited for in-house execution versus external support through contract research organizations.
  • Provide structure-activity relationship and data analysis to enable new structural and chemical design and advance the program.
  • Present synthetic progress, analytical results, data analysis, and strategic insights clearly in cross-functional team meetings.
  • Collaborate with functional leads outside of chemistry.

About the Company

Terray Therapeutics, Inc.

Generative AI-powered small-molecule drug discovery platform

Terray Therapeutics combines wet-lab experimentation with AI to discover small molecule drugs. It builds a data-driven platform that collects over two billion target–ligand binding measurements, adding about 150 million per month, to train deep learning models that predict molecular properties. Its rapid design-make-test-analyze cycle takes under a month per target, allowing millions of molecules to be measured and enabling the identification of potent, selective compounds across many targets. With a focus on immunology and partnerships with pharmaceutical and biotech companies, Terray pursues internal programs and collaborations to accelerate discovery of safe, effective small molecules.

Company size
51-200
Company stage
Series B
Total funding
$195M
Headquarters
Pasadena, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Terray Therapeutics, Inc.

See more jobs